Aroma Sticks
…ctive. It would be recommended that the hospice reintroduce the Aroma Sticks to the service.…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 143 of 876intravenous magnesium sulphateintravenous aminophyllinesubcutaneous adrenalineintravenous ketamineintravenous short-acting beta agonist (SABA)SABAsevere asthmaasthma
…03 to 2.21). There were no frequent serious adverse events. The intravenous magnesium sulphate group had a lower hospitalisation rate (RR=1.52, 95% CI 1.26 to…
PRO-C4Idiopathic pulmonary fibrosis (IPF)IPF
…sely correlated with the change in lung function. High baseline PRO-C4 was associated with increased mortality risk in PFBIO (HR 2.55 …
colchicinecoronary disease
…ho received low-dose colchicine compared with placebo. Low-dose colchicine was associated with a higher volume of calcified plaque, partic…
Ciprofolpropofolcolorectal cancerFirst Affiliated Hospital of Xi’an Jiaotong University
…its gastrointestinal motility, potentially contributing to POI. Ciprofol, a newer general anaesthetic characterised by the addition of a…
ezetimiberosuvastatinhigh-intensity statinmoderate-intensity statinacute myocardial infarctionAMINCT04499859Institutional Review Board of Seoul St. Mary’s HospitalHigh-intensity statin therapy
…randomised 1:1 to receive either moderate-intensity statin with ezetimibe (rosuvastatin 5 mg with ezetimibe 10 mg) or high-intensity stat…
ABS001imiquimodCervical cancer
…y was conducted using low-, mid-, and high-dose formulations of ABS001 to explore potential bell-shaped immunologic effects.Results In…
1022 Engineering a tri-specific antibody targeting PD-1, IL-2, and butyrate to reprogram cold tumors
butyrateCold solid tumorsmicrosatellite stable colorectal cancersPD-1 checkpoint blockadeimmunotherapy
…latory agents interleukin-2 (IL-2) and the microbial metabolite butyrate are under investigation for tumor microenvironment modulation. …
pembrolizumabnivolumabatezolizumabcemiplimabavelumabdurvalumabdocetaxelsolid tumorsClinicalTrials.govN Engl J Med+1 more
…arms (n=8,684 patients) with anti-PD-1/PD-L1 agents (nivolumab, pembrolizumab, atezolizumab, avelumab, durvalumab, cemiplimab) for adult soli…
lisocabtagene maraleucelmosunetuzumabglofitamabaxicabtagene ciloleucelBsAbsB-cell lymphomasFLfollicular lymphomaLBCLrelapsed/refractory B-cell lymphomas+2 more
…32%). In FL, CAR-T products such as axicabtagene ciloleucel and lisocabtagene maraleucel achieve CR rates up to 94%, with median durations of remission …
MaaT034-treatedMaaT034melanomaMC38 tumors
…he capability of MaaT034 microbes to produce these metabolites. MaaT034-treated mice displayed a reduction of the size of cecum, which translat…
Compound Amultiple myelomacutaneous lymphoma
…8 with immunoproteasomes. Treatment of patient tumor cells with Compound A significantly increased the cytotoxic effect of allogeneic and …